InnoCare’s Mesutoclax Granted Breakthrough Therapy Designation by China’s NMPA In a landmark development for China’s oncology therapeutics landscape, InnoCare Pharma Limited (HKEX: 09969; SSE: 688428), a biopharmaceutical company recognized for its focused innovation in cancer and autoimmune disease treatment, announced…
Hansoh Pharma’s Ameile Gains Approval for New Indication in Early-Stage EGFR-Mutant NSCLC Hansoh Pharmaceutical Group Co., Ltd (03692.HK), hereafter referred to as Hansoh Pharma, announced that its innovative product Ameile (almonertinib mesylate tablets) has received approval in China for a…
Johnson & Johnson (NYSE: JNJ) today announced promising new results from the Phase 3 ICONIC-TOTAL study evaluating icotrokinra (JNJ-2113), a first-in-class investigational targeted oral peptide designed to selectively block the IL-23 receptor. The study included adults and adolescents (12 years…
Johnson & Johnson Expands Global Commitment to Strengthen Nursing Workforce and Improve Healthcare Access Johnson & Johnson today announced the expansion of its efforts to champion the nursing workforce and enhance access to quality care for communities worldwide. This initiative…
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) stands as a unique global biopharmaceutical leader, delivering a wide range of medicines to patients around the world. With a legacy spanning over 120 years, Teva has remained steadfast in its mission…
90% of Adults with Chronic Hepatitis Delta Who Cleared Virus on Bulevirtide Stayed Clear Nearly 2 Years After Stopping Treatment Gilead Sciences, Inc. (Nasdaq: GILD) today announced final results from the Phase 3 MYR301 study showing that nearly 90% of…
Global Health Inequities Slashing Lifespans by Decades, WHO Warns A new report by the World Health Organization (WHO) reveals that the root causes of poor health often lie outside the healthcare system — including inadequate housing, limited education, and lack…
WHO Highlights the Importance of Hand Hygiene Over Gloves on World Hand Hygiene Day Hand hygiene remains one of the most effective, affordable, and universal tools in preventing the spread of infections and ensuring high-quality, safe medical care worldwide. While…
73% of healthcare professionals (HCPs) report a disconnect between the availability of cutting-edge treatments and their effective implementation in clinical practice, while 3 in 4 oncologists say the rapid pace of new treatment development feels overwhelming. These insights reinforce Johnson…
BOTOX® Cosmetic Expands Commitment to Female Empowerment with The Confidence Project for Women Entrepreneurs In a bold move to champion female entrepreneurship and narrow the persistent confidence gap between men and women in business, Allergan Aesthetics, an AbbVie company (NYSE:…
Eli Lilly Reports Strong Q1 2025 Financial Results, Driven by Surging Demand for Mounjaro and Zepbound, While Advancing Pipeline Innovations Eli Lilly and Company (NYSE: LLY) has delivered a robust start to 2025, reporting a 45% year-over-year increase in revenue…
Crown Bioscience and NEXT Oncology Expand Strategic Partnership In a significant development that reinforces their shared vision for transforming cancer research and drug development, Crown Bioscience, a global contract research organization (CRO) under the umbrella of JSR Life Sciences and…